Company news
Candel Therapeutics, Inc. news in 2022
Candel Therapeutics, Inc.'s news releases, calls and decks from 2022, newest first.
Candel Therapeutics to Host Virtual R&D Day on December 6, 2022
November 28, 2022
Candel Therapeutics Announces Oral Presentation of Updated Data from its Phase 1 Clinical Trial of CAN-3110 in 41 Patients with Recurrent High-Grade Glioma at the Society for Neuro-Oncology 27th Annual Meeting
November 17, 2022
Candel Therapeutics Announces Late-Breaking Oral Presentation at SITC Annual Meeting with Data on CAN-2409 in Combination with Nivolumab in a Phase 1 Mechanistic Clinical Trial in Patients with High-Grade Glioma
November 10, 2022
Candel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
November 9, 2022
Candel Therapeutics Announces Upcoming Clinical Data Presentations at SITC and SNO
November 6, 2022
Candel Therapeutics Receives Orphan Drug Designation from the European Medicines Agency for CAN-2409 in Glioma
September 14, 2022
Candel Therapeutics Announces Two Executive Leadership Appointments
September 6, 2022
Candel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
August 4, 2022
Candel Therapeutics Appoints Three New Members to its Board of Directors
July 31, 2022
Candel Therapeutics Announces Release of Initial Data on CAN-2409 in a Phase 2 Clinical Trial Showing Cytotoxic T Cell Response and Disease Control in Patients with Non-Small Cell Lung Cancer
May 25, 2022
Candel Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
May 11, 2022
Candel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Highlights
March 28, 2022
Candel Therapeutics Appoints Seshu Tyagarajan, Ph.D., RAC, as Chief Technical and Development Officer
March 1, 2022
Candel Therapeutics Announces $25 Million Non-dilutive Debt Financing Agreement with Silicon Valley Bank
February 28, 2022
Candel Therapeutics Appoints Dr. Francesca Barone as Chief Scientific Officer
February 2, 2022
Decks in 2022
- Investor Day (December 2022)
Investor day · 107 slides · Dec 6, 2022
- Breakfast Event during ASCO 2022 Annual Meeting
Conference · 46 slides · Jun 6, 2022